In summary, our findings report that circGSK3β is an upstream regulator for GSK3β/β-Catenin signaling, which interacts with GSK3β to promote the activity of β-catenin in ESCC cells. The gene discussed is GSK3B; the disease is esophageal squamous cell carcinoma.